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Abstract
Pulmonary vascular resistance (PVR) is traditionally used to describe pulmo-
nary hemodynamic characteristics. However, it does not take into account
pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and
Ca is known as RC time. Previous studies assert that the PVR-Ca relationship
is fixed and RC time is constant between health and disease states. We
hypothesized that RC time was not constant in health and pulmonary vascular
disease. Right heart catheterizations performed in Papworth Hospital over a
6 year period were analyzed. Subjects were divided into those with normal
pulmonary hemodynamics (NPH group; n = 156) and pulmonary arterial
hypertension (PAH group; n = 717). RC time and the right ventricle (RV)
oscillatory power fraction were calculated. RC time for the NPH group
(0.47  0.13 sec) is significantly lower than the PAH group (0.56  0.16 sec;
P < 0.0001). The RV oscillatory power fraction is lower in the NPH group
(P < 0.0001). RC time correlates inversely with the RV oscillatory power frac-
tion in each group. We conclude, there is an inverse relationship between
PVR and Ca, however, this relationship is not always fixed. Consequently, RC
time is significantly lower in health compared to disease with elevated pulmo-
nary artery pressures. PAH leads to a decrease in cardiac efficiency.
Introduction
Classically, pulmonary hypertension has been defined by
mean pulmonary artery pressure (mPAP) and hemody-
namic assessment of patients has focused on pulmonary
vascular resistance (PVR), particularly in therapeutic tri-
als. Despite this mPAP and PVR do not correlate well
with clinical outcomes, whereas measures of right ventric-
ular (RV) function, such as the cardiac index (CI) and
right atrial pressure, generally outperform pulmonary vas-
cular parameters (Swiston et al. 2010). This is postulated
to be due to the failure of PVR to accurately describe
afterload and its impact on the right ventricle. Compli-
ance (Ca) is a component of afterload that can potentially
be derived from commonly used fluid-filled right heart
catheter-based studies. Mahapatra et al. have demon-
strated the importance of Ca by showing a negative
correlation between Ca and mortality in idiopathic
pulmonary arterial hypertension (IPAH) (Mahapatra
et al. 2006).
Many studies have reported an inverse relationship
between PVR and Ca (Reuben 1971; Lankhaar et al. 2006,
2008; Saouti et al. 2009; Bonderman et al. 2011; de Perrot
et al. 2011; Tedford et al. 2012; Hilde et al. 2013;
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Pagnamenta et al. 2013). This relationship has addition-
ally been reported to be fixed. As a consequence, the
product of PVR and Ca (known as RC time) is thought
to be constant. RC time reflects the time constant of the
pulmonary circulation (Reuben 1971). Previous studies
have asserted that RC time is fixed in health, disease and
following therapeutic interventions for pulmonary arterial
hypertension (Lankhaar et al. 2006, 2008; Bonderman
et al. 2011; de Perrot et al. 2011; Skoro-Sajer et al. 2014).
A constant pulmonary RC time implies that compliance
cannot change independently of resistance and therefore it
is not an important independent determinant of outcome.
These conclusions are derived from studies that have all
been in small cohorts and not powered to investigate differ-
ences in RC time. Furthermore, the only study to implicitly
compare the RC time of patients with IPAH and chronic
thromboembolic pulmonary hypertension (CTEPH) with a
comparator group with no pulmonary hypertension
assumed that pulmonary capillary wedge pressure (PCWP)
was negligible (Lankhaar et al. 2006). As a consequence RC
time was calculated using total pulmonary resistance (TPR;
the ratio of mean pulmonary artery pressure (mPAP) to
cardiac output). Although in patients with pulmonary arte-
rial hypertension (PAH) the PCWP is a small fraction of
mPAP, this is not the case in healthy subjects.
We aimed to establish what the RC time is in individu-
als with no PAH and to investigate the physiological rele-
vance of RC time. We hypothesized that RC time is not
the same in health and pulmonary vascular disease. We
report here that RC time is not constant between health
and pulmonary vascular disease and this may have impli-
cations for RV efficiency.
Methods
Subjects
The Papworth Hospital database of right heart catheter-
izations (RHCs) was interrogated to acquire all cases per-
formed between 1/12/2007 and 31/12/2013. This included
patients having RHCs for assessment of pulmonary hemo-
dynamics in the context of pulmonary arterial hyperten-
sion, congenital heart disease, cardiac failure and for
cardiac transplant assessment and follow up.
Right heart catheterization
Right heart catheterizations were performed by expert
cardiologists and pulmonary hypertension physicians
according to international guidelines (Galie et al. 2009).
Quad lumen fluid-filled Swan-Ganz catheters (Edwards
Lifesciences, Irvine) connected to a Philips Haemosphere
(Philips Medical Systems, Surrey, UK) were used for the
procedures. All measurements were taken in the supine
position and at end-expiration during one procedure.
Measurements of systolic pulmonary artery pressure
(sPAP), diastolic pulmonary artery pressure (dPAP),
mPAP, PCWP, heart rate (HR), and cardiac output (CO)
by thermodilution were recorded. Pulmonary artery pres-
sure measurements were taken in the main pulmonary
artery and mPAP was calculated as the average pressure
over a given period of time.
Analysis
Right heart catheterizations with incomplete data that did
not allow calculation of RC time were excluded. RHCs
with negative diastolic pressure gradients (DPG) were also
excluded. The dataset was divided into three groups
(Fig. 1): those with normal pulmonary hemodynamics
(NPH group), those whose hemodynamics met the 5th
World Symposium on Pulmonary Hypertension defini-
tion of pulmonary arterial hypertension (PAH group)
(Hoeper et al. 2013) and those whose hemodynamics fell
outside these two groups (“Other” group).
By definition all patients had a PCWP ≤15 mmHg, this
minimizes the impact of left heart disease and elevated
PCWPs on the RC time analysis (Tedford et al. 2012).
The NPH group was selected by excluding RHCs with
any hemodynamic parameter more than two standard
deviations outside published mean values for healthy
individuals (sPAP 20.81  4.4 mmHg (mean  SD),
dPAP 8.75  3.01, mPAP 13.95  3.27, PCWP 7.97 
2.85, HR 76  14 bpm and CI 4.1  1.26L.min1.m2)
(Kovacs et al. 2009). The “other” group consists of sub-
jects whose hemodynamics did not meet the strict selec-
tion criteria for inclusion in the NPH group or the PAH
group but still have a PCWP ≤15 mmHg.
We have confirmed the fidelity of the database
recorded measurements by a bootstrapping validation of
the pressure waveforms of a subset of 63 randomly
selected subjects with PAH. Database recording was repre-
sentative of pressure waveforms.
Ca was defined as the ratio of stroke volume to pulse
pressure (SV/PP method) (Segers et al. 1999a; Lankhaar
et al. 2006; Mahapatra et al. 2006). RC time was defined
as PVR x Ca (Reuben 1971). The RV oscillatory power
fraction was defined as (Saouti et al. 2010):
Oscillatory power fraction (eq. 1):
¼ Poweroscillatory=ðPoweroscillatory þ PowermeanÞ
 ððsPAP COÞ  ðmPAP COÞÞ=ðsPAP COÞ
 1 ðmPAP=sPAPÞ:
(1)
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For this CO was defined in mL sec1 and pressure in
mmHg. The result is given in watts using the conversion
1W = 7500 mmHg mL sec1.
Statistical analysis
Statistical analyses were carried out using R (http://cran.r-
project.org/) and Graphpad Prism (version 6.04, Graph-
pad Software, CA). Summary statistics (mean  SD) were
calculated and Wilcoxon rank-sum tests were performed
to test the differences in patient characteristics and hemo-
dynamics between NPH and PAH groups.
The relationship between PVR and Ca was examined
using several inverse and exponential models; model fits
were obtained by nonlinear least squares estimation. Data
from both the NPH and PAH groups were included in
the same model, but an indicator function for the PAH
group was introduced to allow separate sets of parameters
for the two groups. The statistical significance of the esti-
mated parameters was suggested by the P-values of t-tests.
Model selection was based on the value of “residual stan-
dard error” (smaller is better) and the number of parame-
ters, that is, when the residual standard errors were the
same for two fitted models, the one with the smaller
number of parameters was preferred. Simple linear
models with least squares estimation were used for exam-
ining the relationships between (1) RC time and mPAP;
(2) RC time and the RV oscillatory power fraction; and
All RHCs
4062
Incomplete data sets
1913
Complete data sets
2149
4 Excluded with 
incorrectly inputted data
All with cases with PCWP 
≤15 mmHg
1289
NPH group (within 2 SD 
of published mean 
values)
215
DPG ≥ 0
156
DPG < 0
59
PAH group 
(mPAP ≥ 25 mmHg & 
PCWP ≤ 15 mmHg)
730
DPG ≥ 0
717
DPG < 0
13
Other group
344
DPG ≥ 0
264
DPG < 0
80
Figure 1. Selection criteria for NPH and PAH groups.
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(3) mPAP and sPAP. F-tests were used to test differences
between the NPH and PAH groups.
Power and sample size calculations were carried out on
Stata version 12 (StataCorp, TX), using the two-sample
sampsi function. The power of referenced studies to find
differences in RC time between two groups were calcu-
lated using published sample sizes, means and standard
deviations as input variables and with a (significance
level) = 0.05. While sample sizes were estimated using
published means and standard deviations as input vari-
ables and with a = 0.05 and power = 0.9.
Ethics
Approval for the study was given by Papworth Hospital
Research and Development and a waiver of written
informed subject consent for the use of anonymized ret-
rospective data was given.
Results
The Papworth Hospital database contained 156 RHCs
which met the hemodynamic definition for inclusion in
the NPH group and 717 met the 5th World Symposium
on Pulmonary Hypertension definition of PAH.
Hemodynamics and RC time
The characteristics of the NPH and PAH groups are sum-
marized in Table 1. Both groups are comprised of
patients undergoing right heart catheterization for assess-
ment and follow up of pulmonary hypertension, heart
failure, congenital heart disease, and heart transplantation.
The mean age of the two groups was statistically different
(NPH group 53.3  13.1 years, PAH group 60.4 
14.6 years; Wilcoxon rank-sum test P < 0.0001). All pul-
monary hemodynamics were significantly different
between the two groups.
RC time is significantly different between the NPH and
PAH groups (0.47  0.13 sec and 0.56  0.16 sec,
respectively; P < 0.0001) (Fig. 2). This difference remains
true if RHCs with negative DPGs are included as well.
The inverse relationship between PVR and Ca proposed
by Tedford et al. (with an indicator function added for
the PAH group) when applied to our data was similar to
our own best fitted (inverse) model (residual errors 0.697
and 0.696, respectively) (Tedford et al. 2012). Therefore,
we validate and use the model proposed by Tedford et al.
This relationship is significantly different between the
NPH group and PAH group (F-test: P = 0.0003) (Fig. 3).
When using TPR to calculate RC time; RC time for
both the NPH and PAH groups are increased but remain
significantly different (0.95  0.32 sec and 0.79 
0.23 sec, respectively; P < 0.0001). This increase is great-
est in the NPH group. The RC times calculated using
TPR and PVR are significantly different for both groups
(P < 0.0001). There remains an inverse relationship
between TPR and Ca (Fig. 4).
Change in RC time with increasing mPAP
There is a gradual increase in RC time with increasing
mPAP rather than a step increase from “normal” pressure
ranges to disease states (Fig. 5). The estimated slope
Table 1. Summary of patient characteristics and hemodynamics.
NPH group PAH group P
n 156 717
Age (years) 53.3  13.1 60.4  14.6 <0.0001
sPAP (mmHg) 24.4  3.5 68.3  21.4 <0.0001
dPAP (mmHg) 9.8  2.4 25.4  8.7 <0.0001
mPAP (mmHg) 16.0  2.3 41.1  12.0 <0.0001
mPAP/sPAP 0.66  0.08 0.61  0.06 <0.0001
PCWP (mmHg) 7.8  2.3 10.5  2.9 <0.0001
CO (L min1) 4.6  1.0 4.3  1.3 0.0049
HR (bpm) 75.2  13.2 78.5  13.3 0.0126
PVR (Wood units) 1.9  0.54 8.0  4.8 <0.0001
PVR (mmHg sec mL1) 0.11  0.03 0.48  0.29
Ca (mL mmHg1) 4.6  1.7 1.6  0.9 <0.0001
RC time (PVR) (sec) 0.47  0.13 0.56  0.16 <0.0001
Data presented as mean  SD. P, compared with Wilcoxon rank-
sum test. NPH group, normal pulmonary hemodynamics group;
PAH group, pulmonary arterial hypertension group; sPAP, systolic
pulmonary artery pressure; dPAP, diastolic pulmonary artery pres-
sure; mPAP, mean pulmonary artery pressure; PCWP, pulmonary
capillary wedge pressure; CO, cardiac output; HR, heart rate; PVR,
pulmonary vascular resistance; Ca, pulmonary artery compliance;
RC time (PVR), PVR-derived RC time.
Figure 2. Distribution of RC time (mean  SD).
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(0.0041) and the correlation value (0.36) are significantly
greater than 0 (P < 0.0001).
Implications for prediction of mPAP from
sPAP
Analysis of the relationship between mPAP and sPAP
reveals two small but significantly different linear relation-
ships (F-test: P < 0.0001) (Fig. 6). The NPH group is best
described by mPAP = (0.47 9 sPAP) + 4.6 mmHg
(r2 = 0.50). The PAH group is best described by the
equation mPAP = (0.53 9 sPAP) + 4.9 mmHg
(r2 = 0.89). The combined group is best described by
mPAP = (0.55 9 sPAP) + 3.5 mmHg (r2 = 0.94).
This implies (as demonstrated in Table 1) that the ratio
of mPAP and sPAP is also different between the two
groups (P < 0.0001). The ratio of mPAP/sPAP correlates
with RC time (PVR) (NPH group: correlation value =
0.41, P < 0.0001; PAH group: correlation value = 0.53,
P < 0.0001). The RV oscillatory power fraction is also a
function of this ratio (eq. 1).
Implications for right ventricular function
RV power parameters for the two groups are summarized
in Table 2. RV total power, RV mean power, RV oscilla-
tory power, and the RV oscillatory power fraction were
all significantly different between the two groups
(P < 0.0001). There is a negative correlation between RC
time and the RV oscillatory power fraction in PAH
Figure 3. Inverse relationships between PVR and Ca. NPH:
y = 10.4/(0.5 + PVR), PAH: y = 10.4/(0.8 + PVR) (F-test
P = 0.0003).
Figure 4. Inverse relationships between TPR and Ca. NPH:
y = 22.1/(1.4 + TPR), PAH: y = 13.5/(0.1 + TPR) (F-test P < 0.0001).
Figure 5. Linear fit of mPAP versus RC time.
y = 0.39 + 0.0041 9 mPAP (P < 0.0001, r2 = 0.128).
Figure 6. Variable relationship between mPAP and sPAP. NPH: y
= (0.47 9 SPAP) + 4.6 (r2 = 0.50); PAH: y = (0.53 9 sPAP) + 4.9
(r2 = 0.89) (F-test: P < 0.0001).
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(Fig. 7; correlation value = 0.53, P < 0.0001). This
implies that a higher proportion of RV power is “wasted”
with reduced RC time in PAH.
The relationship between RC time and the RV oscilla-
tory power fraction is different between the NPH and
PAH groups (Fig. 7). Consequently, despite RC time
being lower in the NPH group; this group also has a
smaller oscillatory power fraction (implying better cardiac
efficiency) compared to the PAH group (34  7.5% vs.
39  6.2%, respectively; P < 0.0001). There is still a neg-
ative correlation between RC time and the RV oscillatory
power fraction in the NPH group (correlation value =
0.41, P < 0.0001).
The values we report are higher than that reported by
Saouti et al. (21% and 23% in their IPAH groups and
25% in their normal pressure group) (Saouti et al. 2010).
However, if we apply the correction factor they proposed
to take into account that systolic pressure is not constant
throughout systole, similar values are obtained (NPH
group 21.0  8.9% and PAH group 26.9  7.4%;
P < 0.0001).
Discussion
We demonstrate that RC time and the relationship
between PVR and Ca is different between health and
pulmonary vascular disease. This is supported by a
recent analysis by Tedford in which he demonstrates that
RC time is lower in subjects with a mPAP <25 mmHg
and PVR <3Wood units (Tedford 2014). It has previ-
ously been demonstrated that RC time varies with
PCWP, in the context of chronic thromboembolic pul-
monary hypertension and weakly with age (Tedford et al.
2012; Mackenzie Ross et al. 2013a). However, it is still
considered to be a constant outside of these specific situ-
ations (Naeije 2013; Tedford 2014). By demonstrating
that RC time is significantly different in a group of “all-
comers” meeting the hemodynamic definition of PAH
compared to hemodynamically “normal” controls we
show that RC time is not a constant – rather it varies
between health and disease states. Explanations for the
lower RC time in low-pressure states include increased
measurement error in low-pressure states, a maximal
compliance beyond which reducing PVR further does
not result in further increases in compliance and possibly
the instances in which PCWP is not the downstream
determinant of PVR (e.g., when alveolar pressure exceeds
PCWP) (Tedford 2014).
RC time is thought to reflect the time constant of the
pulmonary circulation. The time constant of biophysical
systems, exhibiting exponential behavior in time, is the
time taken for a parameter to reduce or increase by 1 –
1/e (63.2%) of the initial value (Reuben 1971; Laughton
and Warne 2003). Therefore, in the pulmonary circula-
tion it is the time for pulmonary artery pressure to decay
by 63.2% during the exponential decay phase of diastole
(i.e., from the dicrotic notch to PCWP). There remains
disagreement whether TPR or PVR-derived RC time val-
ues are more physiologically representative of the pulmo-
nary circulation. We demonstrate differences regardless of
which method is used. The difference between TPR and
PVR-derived RC time is likely a reflection of the influence
of PCWP as shown by Tedford et al. 2012. Furthermore,
Table 2. Right ventricular power parameters.
NPH group PAH group P
RV powertotal (W) 0.25  0.07 0.64  0.24 <0.0001
RV powermean (W) 0.16  0.05 0.39  0.14 <0.0001
RV poweroscillatory (W) 0.09  0.03 0.25  0.11 <0.0001
RV oscillatory power fraction (%) 34  7.5 39  6.2 <0.0001
Data presented as mean  SD. P, compared with Wilcoxon rank-sum test. NPH group, normal pulmonary hemodynamics group; PAH group,
pulmonary arterial hypertension group; W, watts.
Figure 7. Inverse relationship between RC time and the RV
oscillatory power fraction for NPH and PAH groups (NPH:
y = (30.8 9 RC time) + 48.4 (r2 = 0.27); PAH: y = (21.7 9 RC
time) + 51.3 (r2 = 0.33) (F-test: P < 0.0001).
2015 | Vol. 3 | Iss. 4 | e12363
Page 6
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Pulmonary Circulation RC Time is not Constant C. Hadinnapola et al.
in health PCWP accounts for a larger proportion of mean
pulmonary artery pressure.
The RC time, we report, in our normal pulmonary
hemodynamics group is 0.47  0.13 sec. Two other stud-
ies describe similar groups with normal pulmonary hemo-
dynamics. Tedford et al. describe a group of patients with
heart failure (Cohort C Low PCWP group; n = 207)
(Tedford et al. 2012) and Hilde et al. describe a group
with chronic obstructive airways disease with no pulmo-
nary hypertension (n = 72) (Hilde et al. 2013). The RC
time, we calculate, for these two groups is 0.43  0.30 sec
and 0.43  0.27 sec, respectively. This is similar to our
own NPH group. Only one other study has directly com-
pared RC time in control subjects (not meeting the he-
modynamic definition of PAH) to IPAH and CTEPH
patients (Lankhaar et al. 2006). This study used TPR in
the calculation of RC time and was not powered to show
a difference in RC time (“NONPH” vs. “CTEPH” groups:
power = 0.064; “NONPH” vs. “IPAH” groups: power =
0.129).
The subjects with normal pulmonary hemodynamics
reported in the three studies described above as well as
this current study are not necessarily truly “healthy”
given that they have been under investigation for cardio-
respiratory symptoms (Lankhaar et al. 2006; Tedford
et al. 2012; Hilde et al. 2013). Therefore, we performed a
meta-analysis of a systematic review of hemodynamics
from healthy volunteers to ascertain RC time in this
healthy population (Kovacs et al. 2009). Calculating RC
time from this systematic review gives a RC time of
0.39  0.34 sec. This suggests the RC time we report in
our “normal” pulmonary hemodynamics group may be
an overestimate. We acknowledge limitations in these cal-
culations of RC time using published mean data. This
results in potential differences compared to averaging the
RC time of individual data points. The effect of this
should be minimal in large normally distributed datasets,
therefore the assertion that in normal physiology RC time
is lower remains valid.
Other groups have previously investigated the effect of
therapeutic interventions on RC time and concluded that
it remains unchanged (Lankhaar et al. 2008; de Perrot
et al. 2011; Skoro-Sajer et al. 2014). Again these studies
were not powered to show a difference. de Perrot et al.
reported no change in RC time following pulmonary end-
arterectomy (PEA) in patients with CTEPH (de Perrot
et al. 2011). This small study (n = 34; data not available
for power calculation) used TPR to calculate RC time. As
we have demonstrated, TPR-derived RC time is signifi-
cantly different to PVR-derived values especially in those
with normal hemodynamics. Skoro-Sajer et al. reported a
nonsignificant fall in RC time following PEA (Skoro-Sajer
et al. 2014). We calculate the power of their study, to find
a difference in RC time between baseline measurement
and 1 year post PEA, is 0.378. A sample size calculation
from their data suggests that 386 subjects are required.
Furthermore, their data does not distinguish between
patients with a predominately proximal distribution of
chronic thromboembolic disease and those with more dis-
tal disease. We believe that if they were to separate these
two groups in their analysis, they would identify patients
with proximal disease that are more likely to normalize
their hemodynamic post PEA (therefore the sample size
required to demonstrate a reduction in RC time
decreases). This is an approach we have previously taken
and shown a significant decrease in RC time following
normalization of hemodynamics post PEA (Mackenzie
Ross et al. 2013a). We must now revise our own conclu-
sions regarding the effect of PEA on RC time reported by
Mackenzie-Ross et al. Previously, we had suggested that
RC time is lower post PEA because of biomechanical
changes to the proximal pulmonary arteries as a result of
surgery (Mackenzie Ross et al. 2013a). However, with the
revised “normal” RC time, it can be concluded that PEA
actually normalizes RC time in patients with a good out-
come following surgery (defined hemodynamically by a
mPAP < 25 mmHg post PEA).
RV oscillatory power does not contribute to the ejec-
tion of stroke volume (Saouti et al. 2010). Therefore, the
ratio of oscillatory power to total power (the oscillatory
power fraction) can be considered as the proportion of
“wasted” power. In PAH there is a negative correlation
between RC time and the RV oscillatory power fraction
(Fig. 7). This implies that as RC time reduces, the pro-
portion of “wasted” power is increased – reducing RV
efficiency. Therefore, variation in RC time has physiologi-
cal consequences for RV function. Importantly, the rela-
tionship between the RV oscillatory power fraction and
RC time was different between the NPH and PAH
groups. Consequently, cardiac efficiency was better in our
NPH group compared to the PAH group despite their
lower RC time. Others have suggested the variation in RC
time is small and clinically insignificant due to the small
variation in the ratio of total RV power to mean RV
power (Naeije and Delcroix 2014). However, our own
data suggest that the variation in the RV oscillatory power
fraction and consequently the ratio of total to mean RV
power is larger.
It should be noted that the gold standard for calculat-
ing the RV oscillatory power fraction requires measure-
ment of pulmonary artery flow. Saouti et al. conclude
that the RV oscillatory power fraction is a constant based
on their study of 46 patients and using fluid-filled cathe-
ters as we have done ourselves. They argue that the basis
of the constant oscillatory power fraction is due to the
universal proportionality between mPAP and sPAP. In
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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our larger dataset we show that this relationship is not
the same in the NPH and PAH groups.
This lack of proportionality also has implications for
equations predicting mPAP from sPAP. We demonstrate
small but significant differences between the best fit equa-
tions for the PAH and NPH groups. Previous studies
using high-fidelity manometers have suggested there is
proportionality between mPAP and sPAP, allowing a uni-
versal prediction equation (Chemla et al. 2004, 2009;
Syyed et al. 2008). Chemla et al. provide a universal pre-
diction equation of mPAP = (0.61 9 sPAP) + 2. This is
similar to our own equations. They acknowledge that in
narrower hemodynamic ranges and specific patient sub-
groups alternative equations for predicting mPAP from
sPAP maybe more accurate (Chemla et al. 2004).
Concerns have previously been raised regarding the use
of fluid-filled catheters rather than high-fidelity manome-
ters. In particular, there are concerns regarding wave
reflection and the time response of fluid-filled catheters,
especially at higher pressures, in the context of proximal
obstructions in CTEPH (Chemla et al. 2013). These issues
have been addressed previously (Mackenzie Ross et al.
2013b). This study does not use time-dependent hemody-
namic parameters, minimizing any errors introduced by
the use of fluid-filled catheters. In addition, direct com-
parison in an animal model of high-fidelity microma-
nometer tipped catheters and fluid-filled Swan-Ganz
catheters (which are used commonly in clinical practice)
has shown similar results (Pagnamenta et al. 2013). More
recently, Bachman et al. have shown that no clinically sig-
nificant biases are found when comparing high- fidelity
micromanometer tipped catheter and fluid-filled catheter
results (Bachman et al. 2013).
The definition of pulmonary compliance must also be
taken into consideration. Previous studies have been het-
erogeneous in their methodology. This has led to signifi-
cant variations in RC time even within the same disease
group and using TPR to derive RC time (Lankhaar et al.
2006; Saouti et al. 2009). The benefits and drawbacks of
different methods of calculating Ca have been discussed
and their impact on RC time assessed (Lankhaar et al.
2006, 2008). The SV/PP method can be thought as the
upper limit of compliance, as it assumes that the proxi-
mal pulmonary arteries are exposed to the entire SV, like
a closed system (Segers et al. 1999a,b). However, Segers
et al. have shown a good correlation between the SV/PP
method and the pulse pressure method (considered the
gold standard) across several hemodynamic states (Segers
et al. 1999a). Additionally, compliance, determined by the
SV/PP method, has been correlated with mortality in
IPAH and its simplicity may mean it is more accurate
than other methods (Mahapatra et al. 2006; Lankhaar
et al. 2008). Quantification of pulmonary artery vascular
volume may also yield additional information in disease
states.
We demonstrate that RC time is not constant between
health and diseases with elevated pulmonary artery pres-
sures. Despite this, there remains an inverse relationship
between PVR and Ca in all of the studies presented. This
relationship is not immutably fixed between health and
disease states; although the differences are subtle. We
demonstrate that a variable RC time has potential physio-
logical consequences for RV function with a negative cor-
relation with the RV oscillatory power fraction.
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